20 May 2013
Keywords: first, patient, dosed, kudos, oral, cancer, agent
Article | 01 August 2005
KuDOS Pharmaceuticals, a UK drug development company that targets DNA damage sensing and signalling to improve the treatment of cancer, ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
1 August 2005
8 August 2005
© 2013 thepharmaletter.com